RPL22L1 and neoplasm: These infiltrating immune cells influence tumor progression and the effectiveness of immunotherapy.43 Notably, some ribosomal proteins are involved in regulating immune infiltration in the TME.20, 44 However, the effect of RPL22L1 in the immune infiltration of LUAD is not fully clear.